Skip to content

The influence of high frequency 10Hz repetitive transcranial magnetic stimulation (rTMS) on experimental pain measured through quantitative sensory testing in healthy subjects.

The influence of high frequency 10Hz repetitive transcranial magnetic stimulation (rTMS) on experimental pain measured through quantitative sensory testing in healthy subjects. - rTMS on experimental pain in healthy subjects.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON43483
Enrollment
20
Registered
2016-03-09
Start date
2016-02-01
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pijn, Centraal Zenuwstelsel: Verwerking van pijn. Pain

Interventions

All subjects participate in two conditions in random sequence. These conditions contain either sham rTMS or active 10Hz rTMS. The rTMS is 10 Hz high frequency rTMS, stimulating the motor cortex with

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Subject is or is older than 18 years. 2. Subjects should be naïve to rTMS treatment

Exclusion criteria

Exclusion criteria: 1. Subject has an condition with risk of magnetic interference while using rTMS. 2. Subject has an condition with increased or uncertain risk of inducing epileptic seizures while using rTMS(active or history of epilepsy, lesions of the brain, interfering drugs/medication) 3. Subject has an conditions with increased risk of other events while using rTMS (pregnancy, severe hearth disease) 3. Subject has an history of, clinical signs/symptoms of, or concomitant acute or chronic pain.

Design outcomes

Primary

MeasureTime frame
Analgesic effect is measured through QST. QST measurements will be performed using different modalities, e.g. mechanical pressure, electrical stimulation and conditioned pain modulation (CPM). The primary outcome is pressure pain threshold (PPT).

Secondary

MeasureTime frame
Secondary outcomes are: Electric Sensation Threshold in mA, Electric Pain Threshold in mA, Electric Pain Tolerance Threshold in mA, Conditioned Pain Modulation Paradigm in kPa for PPT and mA for EPPT and VAS-score (0-10). Mask validity tests in % (for both rTMS and sham). And Adverse events.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)